Targacept, Inc. Reports Fourth Quarter and 2011 Financial Results

February 22, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the fourth quarter and year ended December 31, 2011.

Twitter
LinkedIn
Facebook
Email
Print

Earnings